4: sales network
Already partnering with the largest stroke treatment provider ($11 billion USD revenue ) . They see value in partnering with Nico because more identification of clots leads to more surgeries and more sale of their products. Also, large players such as Siemens, Toshiba would be open to reselling Nico as an add on. Considering the size of the hospital sector, potential is huge .
- Forums
- IPOs
- Nico.lab Pre IPO
Nico.lab Pre IPO, page-15
-
- There are more pages in this discussion • 687 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)